A Bioinspired Small Diameter Vascular Conduit
仿生小直径血管导管
基本信息
- 批准号:7649262
- 负责人:
- 金额:$ 77.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-15 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelArteriesArtificial OrgansBiochemicalBiologicalBiomechanicsBiomimetic MaterialsBiopolymersBioprosthesis deviceBloodBlood Vessel ProsthesisBlood VesselsCaliberCardiacCell physiologyCharacteristicsChemicalsClinicalClinical ResearchCollagenCollagen Type IDevelopmentElastinElastin FiberEndothelial CellsEngineeringEnvironmentFamilyFatigueFiberFoundationsGenerationsGenetic TechniquesImplantIn VitroInfiltrationMechanicsMetabolicMethodologyMolecularMolecular GeneticsMolecular StructureOperative Surgical ProceduresPapioPerformancePhysiologicalPlasticsPorosityProcessPropertyProsthesisProteinsQuaternary Protein StructureRouteSchemeSiteSmooth Muscle MyocytesSolutionsSolventsStructural ProteinStructureSupport SystemTechniquesTensile StrengthTestingTissuesVascular Graftanalogbasedesigndesign and constructionimplantationin vivoinnovationmathematical modelmechanical behaviormimeticsmonolayernanofabricationresilienceresponsescaffoldsolid statesynthetic proteintool
项目摘要
DESCRIPTION (provided by applicant): A clinically durable small diameter vascular graft may be achievable by optimizing the mechanical properties of an arterial bioprosthesis, as well as other biologically related characteristics. We believe that the molecular structure and supramolecular organization of native type I collagen and elastin fiber assembly establishes an important paradigm for the design of an arterial substitute composed of bio-inspired protein fiber analogues. Specifically, we intend to:
(1) Determine the molecular level features of collagen and elastin fiber analogues that influence the mechanical behavior and physiochemical properties of protein-based fiber networks. Elastin and collagen analogues will be produced by biosynthetic and chemical schemes and processed into fiber networks by nanofabrication techniques. Both solution and solid state methodologies will be used to define material structure-property relationships.
(2) Identify the micro scale characteristics of a protein fiber reinforced biopolymer composite that dictate mechanical responses relevant to the design of an arterial substitute. The mechanical behavior of both single and multicomponent fiber network composites will be investigated by static and dynamic mechanical testing under physiologically relevant conditions. In the process, constitutive mathematical models will be applied to assist in conduit design, as well as in the subsequent analysis of construct remodeling.
(3) Define the morphological and structural remodeling of a collagen and elastin fiber reinforced vascular construct in vivo. Both acellular constructs, as well as conduits seeded with autogenous endothelial cells will be examined in a baboon animal model. Specifically, the effect of the local biological and mechanical environment on short- and long-term conduit properties, including patency and biostability will be defined.
Lay summary: Optimizing mechanical and other biologically related properties may be an important step in the development of a small diameter arterial prosthesis critical to the fields of cardiac, plastic, and vascular surgery, as well as to the successful implantation of artificial organs and metabolic support systems.
描述(由申请人提供):可以通过优化动脉生物繁殖发生的机械性能以及其他与生物学相关的特征来实现临床耐用的小直径血管移植物。我们认为,天然I型胶原蛋白和弹性蛋白纤维组件的分子结构和超分子组织为设计由生物启发的蛋白质纤维类似物组成的动脉替代品建立了重要的范式。具体来说,我们打算:
(1)确定影响基于蛋白质的纤维网络的机械行为和生理学特性的胶原蛋白和弹性纤维类似物的分子水平特征。弹性蛋白和胶原蛋白类似物将由生物合成和化学方案产生,并通过纳米制作技术加工成纤维网络。 解决方案和固态方法都将用于定义材料结构 - 特质关系。
(2)确定蛋白质纤维增强生物聚合物复合材料的微尺度特征,该复合物复合材料决定了与动脉替代品设计相关的机械响应。单一和多组分纤维网络复合材料的机械行为将通过生理相关条件下的静态和动态机械测试研究。在此过程中,构型数学模型将用于协助导管设计,以及随后对构造重塑的分析。
(3)定义体内胶原蛋白和弹性纤维增强血管构建体的形态和结构重塑。两种细胞构建体,以及用自源内皮细胞播种的辅导构建物将在狒狒动物模型中检查。具体而言,将定义局部生物学和机械环境对短期和长期导管特性的影响,包括通畅和生物稳定性。
摘要摘要:优化机械和其他与生物学相关的特性可能是发展对心脏,塑料和血管手术领域至关重要的小直径动脉假体的重要步骤系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elliot Chaikof其他文献
Elliot Chaikof的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elliot Chaikof', 18)}}的其他基金
Structure-Guided Design of Intestine-Selective AHR Agonists for Restoration of Gut Barrier Integrity in IBD
用于恢复 IBD 肠道屏障完整性的肠道选择性 AHR 激动剂的结构引导设计
- 批准号:
10627922 - 财政年份:2022
- 资助金额:
$ 77.73万 - 项目类别:
Structure-Guided Design of Intestine-Selective AHR Agonists for Restoration of Gut Barrier Integrity in IBD
用于恢复 IBD 肠道屏障完整性的肠道选择性 AHR 激动剂的结构引导设计
- 批准号:
10420534 - 财政年份:2022
- 资助金额:
$ 77.73万 - 项目类别:
Sulfated Poly-Amido-Saccharide (sulPAS) Biomaterials as Anticoagulants
作为抗凝剂的硫酸化聚酰胺糖 (sulPAS) 生物材料
- 批准号:
10649522 - 财政年份:2022
- 资助金额:
$ 77.73万 - 项目类别:
Clot-Targeted Antithrombotics for Venous Thromboprophylaxis
用于预防静脉血栓的凝块靶向抗血栓药物
- 批准号:
10474980 - 财政年份:2019
- 资助金额:
$ 77.73万 - 项目类别:
Clot-Targeted Antithrombotics for Venous Thromboprophylaxis
用于预防静脉血栓的凝块靶向抗血栓药物
- 批准号:
9795082 - 财政年份:2019
- 资助金额:
$ 77.73万 - 项目类别:
Delivery Technologies for In Vivo Genome Editing
体内基因组编辑的传递技术
- 批准号:
9805901 - 财政年份:2019
- 资助金额:
$ 77.73万 - 项目类别:
Clot-Targeted Antithrombotics for Venous Thromboprophylaxis
用于预防静脉血栓的凝块靶向抗血栓药物
- 批准号:
10229398 - 财政年份:2019
- 资助金额:
$ 77.73万 - 项目类别:
Delivery Technologies for In Vivo Genome Editing
体内基因组编辑的传递技术
- 批准号:
10664097 - 财政年份:2019
- 资助金额:
$ 77.73万 - 项目类别:
相似国自然基金
通过自主研发的AAV8-TBG-LOX-1基因治疗技术祛除支架区域氧化型低密度脂蛋白抑制支架内新生动脉粥样硬化研究
- 批准号:82370348
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
白血病抑制因子在诱导性多能干细胞分化的血管内皮前体细胞抑制动脉内膜增生中的作用
- 批准号:82370415
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
缝隙连接Cx43磷酸化修饰介导钙信号传递异常参与尼古丁致肺动脉重构的分子机制
- 批准号:82373622
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
HMGCS2调控巨噬细胞训练免疫对动脉粥样硬化斑块“维稳”的机制研究
- 批准号:82373884
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于NLRP3炎性小体驱动的巨噬细胞焦亡研究穗花杉双黄酮抗动脉粥样硬化作用
- 批准号:82360786
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Contribution of Endothelial Planar Cell Polarity pathways in Blood Flow Direction Sensing
内皮平面细胞极性通路在血流方向传感中的贡献
- 批准号:
10750690 - 财政年份:2024
- 资助金额:
$ 77.73万 - 项目类别:
Sexual dimorphism and menopause in the interaction between immune cells and neurovascular coupling
免疫细胞与神经血管耦合相互作用中的性别二态性和更年期
- 批准号:
479498 - 财政年份:2023
- 资助金额:
$ 77.73万 - 项目类别:
Operating Grants
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 77.73万 - 项目类别:
Wearable, Wireless Deep-tissue Sensing Patch for Continuous Monitoring of Recovery from Microsurgical Tissue Transfer
可穿戴式无线深层组织传感贴片,用于连续监测显微外科组织转移的恢复情况
- 批准号:
10637093 - 财政年份:2023
- 资助金额:
$ 77.73万 - 项目类别:
Regulation of Vascular Calcification by Adventitial Endothelial Cells
外膜内皮细胞对血管钙化的调节
- 批准号:
10642619 - 财政年份:2023
- 资助金额:
$ 77.73万 - 项目类别: